The review found no eligible studies for this question.
It is very uncertain whether intrauterine injection of autologous platelet‐rich plasma changes live birth (or ongoing pregnancy) compared with no intervention (very low certainty).
It is very uncertain whether intraovarian injection of autologous platelet‐rich plasma changes ongoing pregnancy compared with no intervention (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether intraovarian injection of autologous platelet‐rich plasma changes clinical pregnancy compared with no intervention (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether intrauterine injection of autologous platelet‐rich plasma changes miscarriage compared with no intervention (very low certainty).
It is very uncertain whether intrauterine injection of autologous platelet‐rich plasma changes clinical pregnancy compared with no intervention (very low certainty).
It is very uncertain whether intrauterine injection of autologous platelet‐rich plasma changes adverse events: ectopic pregnancy compared with no intervention (very low certainty).
It is very uncertain whether boric acid changes reduction in level of contamination by particles >5 um (droplets) at… compared with water (very low certainty).
Etoricoxib showed no clear difference in exacerbation of IBD compared with placebo (low certainty).
Electrical stimulation plus pelvic floor muscle training (PFMT) may leads to higher participants with improvement in urgency urinary incontinence compared with PFMT alone (low certainty).
Tailoring asthma treatment using fractional exhaled nitric oxide probably leads to lower number of participants who had ≥ 1 exacerbations over study period… compared with clinical symptoms (moderate certainty).
It is very uncertain whether tailoring asthma treatment using fractional exhaled nitric oxide changes number of asthma exacerbations per 52 weeks (exacerbation rate) compared with clinical symptoms (very low certainty).
Intrauterine infusion/injection of autologous platelet‐rich plasma may leads to higher adverse events: preterm delivery compared with no intervention or placebo (low certainty).